Table 1.
Patient characteristics
| Underlying condition | No. of patients | Gender [f/m] | Age [y] median/range | Immunosuppressive patients [%] | Patients with anti-infective pre-treatment [%] |
|---|---|---|---|---|---|
| Patients with underlying haematological or oncological disease | 29/70 (41%) | 12/17 | 8/0–25 | 26/29 (90%) | 20/30 (67%) |
| After bone marrow transplantation | 6/70 (9%) | 3/3 | 9/3–14 | 6/6 (100%) | 5/6 (83%) |
| After solid organ transplantation | 6/70 (9%) | 5/1 | 6.5/1–14 | 6/6 (100%) | 3/6 (50%) |
| Chronic lung disease | 10/70 (14%) | 7/3 | 9/0–14 | 1/10 (10%) | 6/10 (60%) |
| Neuromuscular disease | 3/70 (4%) | 1/2 | 4/0–22 | 1/3 (33%) | 0/3 (0%) |
| Other | 5/70 (7%) | 5/0 | 5/1–16 | 1/5 (20%) | 1/5 (20%) |
| Previously healthy | 11/70 (16%) | 3/8 | 2.5/0–14 | 0/11 (0%) | 1/11 (9%) |
| Total | 70 | 36/34 | 6.5 (0–25) | 41/70 (59%) | 36/70 (51%) |
f Female, m Male, y Years